Unlocking The Biological Potential of Quinolines: A Review

Abstract

Quinoline is an aromatic heterocyclic compound with a double-ring structure of benzene and pyridine, known for its diverse biological activities. It has been extensively studied for its antimalarial, antibacterial, anticonvulsant, anti-inflammatory, and analgesic properties. Quinoline derivatives, such as chloroquine, quinine, and mefloquine, are key treatments for malaria, while quinoline-based antibiotics like fluoroquinolones target bacterial infections. Research into its anticonvulsant, anti-inflammatory, and pain-relieving effects further highlights its therapeutic potential. Due to its versatility, quinoline remains a promising scaffold for developing new treatments in medicine.

Keywords

Introduction

Quinoline is an organic compound that belongs to the aromatic heterocyclic class, characterized by its unique double-ring structure consisting of a benzene ring and a pyridine ring fused at two adjacent carbon atoms. This structure gives quinoline its distinct chemical and biological properties, making it a valuable compound in various fields, especially in medicine.

Quinoline has been widely studied for its significant biological activities, which include antimalarial, antibacterial, anticonvulsant, anti-inflammatory, and analgesic effects. These properties have been harnessed in the development of numerous therapeutic agents, particularly in the treatment of malaria and bacterial infections, as well as in managing seizures and chronic pain.

In particular, quinoline derivatives have played an essential role in combating malaria, with drugs such as chloroquine, quinine, and mefloquine being key treatments for the disease. Quinoline-based compounds have also contributed to the development of antibiotics, notably the fluoroquinolones, which are used to treat bacterial infections. Moreover, research into quinoline’s anticonvulsant, anti-inflammatory, and analgesic properties has revealed its potential for treating a range of conditions, from epilepsy to chronic pain and inflammation.

In this context, quinoline’s diverse biological activities make it a highly versatile and promising scaffold for the development of novel therapeutic agents. Its ongoing research continues to shed light on its mechanisms of action, optimizing its use in clinical settings and offering hope for more effective treatments in the future.

QUINOLINE

Quinoline, any of a class of organic compounds of the aromatic heterocyclic series characterized by a double-ring structure composed of a benzene and a pyridine ring fused at two adjacent carbon atoms. 

PROPERTIES

Chemical formula – C₉ H₇ N

Molar mass -129.16g/mol

Appearance -colourless oily liquid

Density-1.093g/ml

Boiling point - −15 °C (5 °F; 258 K)

Melting point-237 °C (459 °F; 510 K) , 760 mm Hg; 108–110 °C (226–230 °F), 11 mm Hg

Other IUPAC name -1-Benzopyridine,Benzo[b]pyridine

Solubility in water-Slightly soluble

Solubility -Soluble in alcohol,ether and carbon disulfide

BIOLOGICAL ACTIVITY OF QUINOLINE

Antimalarial, Antibacterial, Anticonvulsant, Anti inflammatory, Analgesic.

Antimalarial Activity

Quinoline-containing antimalarial drugs like chloroquine, quinine, and mefloquine are key treatments for malaria, acting primarily by interfering with the digestion of hemoglobin in the malaria parasite. Chloroquine accumulates in the parasite's acidic vacuole, inhibiting the polymerization of hemoglobin breakdown products, causing toxic buildup that kills the parasite. Mefloquine and quinine, being more lipophilic, don’t concentrate as much in the vacuole but may have alternative mechanisms of action, possibly interacting with proteins like stomatin on erythrocytes before entering the parasite. As resistance to these drugs increases, particularly through a parasite version of P-glycoprotein, understanding the molecular mechanisms behind this resistance is crucial for developing new strategies to combat malaria.

Antibacterial Activity

The quinoline moiety has historical significance due to its presence in the Cinchona alkaloids, quinine and quinidine, which were the first effective treatments for malaria. Building on this, synthetic quinoline-based drugs like chloroquine, mefloquine, and amodiaquine remain in clinical use today for malaria treatment. In the 1960s, a by-product of chloroquine synthesis led to the discovery of nalidixic acid and, later, the fluoroquinolone class of antibiotics, which are effective against Enterobacteriaceae, including pathogens like E. coli and Salmonella. These drugs specifically target bacterial DNA topoisomerases. Additionally, quinoline derivatives like bedaquiline have been developed for antibacterial use, with bedaquiline being a key treatment for multi-drug-resistant tuberculosis by inhibiting mycobacterial ATP synthase.

Anticonvulsant Activity

Quinoline derivatives have gained attention for their anticonvulsant properties, showing potential in preventing or controlling seizures. Several studies have highlighted that quinolines, particularly those incorporating triazole rings, display strong anticonvulsant effects when tested in animal models, including the widely used maximal electroshock (MES) test. While the precise mechanism underlying their anticonvulsant activity remains unclear, it is believed that quinolines may interact with various neurotransmitter systems in the brain, potentially modulating excitability and synaptic transmission. Furthermore, the activity of these compounds can be significantly influenced by the type and position of substituents on the quinoline ring. For example, the addition of halogen atoms, particularly fluorine, or certain aromatic groups can enhance their anticonvulsant potency, suggesting that structural modifications play a crucial role in optimizing their therapeutic effects. This makes quinoline derivatives a promising scaffold for the development of new antiepileptic drugs, with a focus on tailoring substituent patterns to maximize efficacy and reduce side effects.

Anti inflammatory Activity

Quinolines are gaining attention for their broad pharmacological properties, particularly in targeting inflammation. They can inhibit enzymes like cyclooxygenase-2 (COX-2), which reduces the production of pro-inflammatory prostaglandins, offering potential anti-inflammatory and pain-relieving effects. Unlike traditional NSAIDs, quinolines may selectively target COX-2 without affecting COX-1, potentially reducing gastrointestinal side effects. Additionally, quinolines act as antagonists of the transient receptor potential vanilloid 1 (TRPV1) receptor, which plays a role in pain sensation, offering potential benefits for chronic pain management. Beyond inflammation, quinolines have shown promise in anticancer, antimalarial, and antimicrobial research, highlighting their versatility as therapeutic agents.

Analgesic Activity

Quinolines, a class of heterocyclic compounds, have shown significant analgesic activity due to their ability to interact with pain pathways, both centrally and peripherally. Their analgesic effect is often linked to the inhibition of enzymes like cyclooxygenase (COX), which play a key role in inflammation and pain signaling. The analgesic properties of quinoline derivatives are influenced by the type and position of substituents on the quinoline ring. Research has demonstrated that several quinoline derivatives exhibit potent analgesic effects, comparable to established pain medications, suggesting their potential as candidates for the development of new pain treatments.

CONCLUSION

Quinolines are a class of heterocyclic compounds displayed a wide range of biological activities. Therefore this nucleus was involved in the drug discovery and drug development processes. Quinolines derivatives showed good biological activities such as Antimalarial, Antibacterial, Anticonvulsant, Anti inflammatory, Analgesic. etc. The present review is about the physical properties, synthesis of  quinoline derivatives and focused on its biological outcomes.

ACKNOWLEDGMENT

We are highly indebted to our esteemed guide. Assistant Professor Lakshmi Gopal R, M. Pharm and co-guide Associate Professor Dr SREEJA S, M. Pharm, Ph .D .for their support, unending encouragement and advice, which helped us for the successful completion of this article.

REFERENCES

1. Mohd Shoeb, Priya D. Thakre, Punam N. Dharpure, & Mohsin Khan. (1). Quinoline Derivatives: A Comprehensive Review of Synthesis, Biological Activities, and Pharmaceutical Applications( 2024) july 3. International Journal of Pharma Professional’s Research (IJPPR), 15(3), 35-51.
2. S.M . Medvedeva ,A. petrou , M.Fesatidou ,A.Gavalas, A.A. Geronikaki , P. I.Savosina Anti-inflammatory action of new hybrid N-acyl-[1,2]dithiolo-[3,4c]quinoline-1-thione.   22 may (2024 )SAR and QSAR in Environmental Reasearch 35(5); 343-66
3. Sujeet Kumar Gupta, Ashutosh Mishra . Synthesis, Characterization & Screening for Anti-Inflammatory & Analgesic Activity of Quinoline Derivatives Bearing Azetidinones Scaffolds.( 2016): National Institutes of Health(NIH)15(1);31-43.
4. Megha Pankaj .Ambatkar, Rishabh Devendra Agade and Pramod Bhujangrao khedekar Synthesis and Antinociceptive Activity of 5-Amino (N-Substitutedcarboxamide)quinoline Derivatives Targeting TRPV1 Receptor . 21 june(2024),Indian Journal of Pharmaceutical Education and Research(ijper) 2024 58(3): 976-83
5. Geraldo José da Silva Neto a, Suellen Maria Albuquerque da Silva b, Daniele Costa Souza Barros a, Alyne Almeida de Lima b, Max Denisson Maurício Viana c, Magna Suzana Alexandre Moreira b, Mario Roberto Meneghetti a, Eliane Aparecida Campesatto b Evaluation of the biological activity of different 4-aminoquinolines for the development of new drugs against painful and inflammatory disorders.  December (2023) ,European Journal of Medicinal Chemistry Reports(ejmcr) volume 9,(100115)
6. Igor V. Ukrainets1*, Olga V. Gorokhova1, Xeniya V. Andreeva1 and Galina Sim Synthesis, structure and analgesic activity of 1-(2-cyanoethyl)- 4-hydroxy-2-oxo-1,2dihydroquinoline-3-carboxylic acid hydroxy-alkylamides and their derivatives.   (2012)International Journal of Pharmacy and Pharmacology(ijpp)volume 1(3)  pp.034-040. 2326-7257
7. Abhinav Prasoon Mishra1 , Preeti Verma2 and Riya a 2Design synthesis and evaluation of anti inflammatory,analgesic,and antipyretic activity of 7-amino quinoline derivatives. 9 December( 2022),World Journal of Pharmaceutical Research(wjpr) 12(4), 2277-7105
8. Nagy M Khalifa, Mohamed A Al-Omar, Ahmed A Abd El-Galil, Mohammed Abd ElReheem Anti-inflammatory and analgesic activities of some novel carboxamides derived from 2-phenyl quinoline candidates. 04 JULY( 2017 ),28(2)869-874 0970938X.
9. Orazio Mazzoni ,Giovanni Esposito ,Maria vittoria Diurno, Diego Brancaccio , Alfonso Carotenuto, PaoloGrieco , Ettore Novellino ,Walter Fillippelli Synthesis and Pharmacological Evaluation of Some 4-Oxo-quinoline-2-carboxylic Acid Derivatives as Anti-inflammatory and Analgesic Agents. 11 october National Institutes of Health(NIH) 343(10)p.561-69
10. Shan-ShanZhang,Qiu-WanTan,Li-PingGuanAntioxidant,antiinflammatory,antibacterial,and analgesic activities and mechanisms of quinolines,indoles and related deriovatives(2021) National Institutes of Health(NIH) 21(16), 2261-2275,2021.
11. Rizk Elsayed Khidre,Bakr Fathy Abdel-Wahab,Farid  Abdel-Rehem Badria New quinoline-        based compounds for analgesic and anti-inflammatory evaluation(2011)Bentham science publishers 8(7),p.640-48,2011.
12. Mona Elsayed Aboutabl, Ahmed Ragab Hamed,Mohamed Farouk Hamissa,Emad Khairy Ahmed Anti-Inflammatory and Analgesic Activities of 7-Chloro-4-(Piperazin-1-yl) Quinoline Derivative Mediated by Suppression of Inflammatory Mediators Expression in Both RAW 264.7 and Mouse Models(2020) Pharmaceutical Sciences(pharm sci.)2020;27(3):326-38.
13. Tejinder Kaur, Divya Dhawal Bhandari Annotated review on various biological activities of quinoline molecule(2023) Biointerface Research in Applied Chemistry(4)13 2023,355.
14. Vivek Yadav, Jurnal Reang,Vinita Sharma,Jaseela Majeed,Prabodh Chander Sharma,Kalicharan Quinoline-derivatives as privileged scaffolds for medicinal and pharmaceutical chemist:A comprehensive review(2022) National Institutes of Health(NIH)100(3) 389-418,2022.